Vir Biotechnology, Inc. - Common Stock (NQ:VIR)
5.630
+0.160
(+2.93%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 14, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,260,580 |
| Open | 5.360 |
| Bid (Size) | 5.370 (100) |
| Ask (Size) | 5.600 (100) |
| Prev. Close | 5.470 |
| Today's Range | 5.360 - 5.860 |
| 52wk Range | 4.155 - 14.45 |
| Shares Outstanding | 133,976,538 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
Earnings Scheduled For August 6, 2025 ↗
August 06, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
August 27, 2025
Vir (VIR) Q2 Revenue Drops 61% ↗
August 07, 2025
Where Vir Biotechnology Stands With Analysts ↗
July 11, 2025
Frequently Asked Questions
Is Vir Biotechnology, Inc. - Common Stock publicly traded?
Yes, Vir Biotechnology, Inc. - Common Stock is publicly traded.
What exchange does Vir Biotechnology, Inc. - Common Stock trade on?
Vir Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vir Biotechnology, Inc. - Common Stock?
The ticker symbol for Vir Biotechnology, Inc. - Common Stock is VIR on the Nasdaq Stock Market
What is the current price of Vir Biotechnology, Inc. - Common Stock?
The current price of Vir Biotechnology, Inc. - Common Stock is 5.630
When was Vir Biotechnology, Inc. - Common Stock last traded?
The last trade of Vir Biotechnology, Inc. - Common Stock was at 11/14/25 04:00 PM ET
What is the market capitalization of Vir Biotechnology, Inc. - Common Stock?
The market capitalization of Vir Biotechnology, Inc. - Common Stock is 754.29M
How many shares of Vir Biotechnology, Inc. - Common Stock are outstanding?
Vir Biotechnology, Inc. - Common Stock has 754M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.